Acupoint herbal patching for children with recurrent respiratory tract infection: A systematic review and

Boram Lee1, Chan-Young Kwon2, Gyu Tae Chang3

  • 1Clinical Medicine Division, Korea Institute of Oriental Medicine, 1672 Yuseongdae-ro, Yuseong-gu, Daejeon, 34054, Republic of Korea.

Insights

Acupoint herbal patching (AHP) effectively reduces respiratory tract infection (RTI) frequency and duration in children. This safe therapy also appears to enhance immune function, offering a promising treatment for pediatric recurrent RTIs.

Area of Science:

  • Integrative Medicine
  • Pediatric Pulmonology
  • Traditional Chinese Medicine

Background:

  • Recurrent respiratory tract infections (RRTI) pose a significant health challenge in pediatric populations.
  • Acupoint herbal patching (AHP) is a traditional therapy utilized for managing pediatric RRTI.
  • The safety and efficacy of AHP for pediatric RRTI require systematic evaluation.

Purpose of the Study:

  • To conduct a systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating AHP for pediatric RRTI.
  • To assess the efficacy of AHP in reducing the incidence and duration of respiratory tract infections (RTIs) in children.
  • To analyze the safety profile of AHP when used as monotherapy or adjunctive therapy.

Main Methods:

  • A comprehensive literature search was performed across eleven databases up to January 2020.
  • Included studies were randomized controlled trials (RCTs) involving pediatric patients diagnosed with RRTI.
  • AHP was considered as either a standalone treatment or an add-on therapy.

Main Results:

  • Twenty-two RCTs encompassing 3579 participants were included in the meta-analysis.
  • AHP significantly decreased the annual outbreaks and duration of RTIs compared to placebo at 1, 2, and 3-year follow-ups.
  • No serious adverse events were reported, indicating a favorable safety profile for AHP.

Conclusions:

  • Acupoint herbal patching (AHP) demonstrates promising efficacy in reducing the frequency and duration of RTIs in pediatric patients.
  • AHP may contribute to improved immune function in children suffering from recurrent respiratory tract infections.
  • The findings support AHP as a potentially safe and effective therapeutic option for pediatric RRTI.
Abstract

Related Concept Videos